# TriplePoint Venture Growth BDC Corp.: Form 10-Q for the period ended Mar 31, 2021

- Company: [TriplePoint Venture Growth BDC Corp.](/companies/tpvg.md) (CIK 1580345)
- Form: 10-Q
- Filed: 2021-05-05
- Accepted by EDGAR: May 5, 2021, 16:30 ET
- Period: 2021-03-31
- Accession: 0001580345-21-000020
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1580345/000158034521000020/tpvg03312110-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1580345/000158034521000020/

## Management's discussion and analysis

As filed, 69,569 characters.

### Forward-Looking Statements

The information contained in this section should be read in conjunction with our consolidated financial statements and related notes and schedules thereto appearing elsewhere in this Quarterly Report on Form 10-Q. Except as otherwise specified, references to “the Company”, “we”, “us”, and “our” refer to TriplePoint Venture Growth BDC Corp. and its subsidiaries.

This Quarterly Report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, our beliefs, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” and variations of these words and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q include statements as to:

- our and our portfolio companies’ future operating results and financial condition, including the ability of us and our portfolio companies to achieve our respective objectives;
- our business prospects and the prospects of our portfolio companies;
- our relationships with third parties, including but not limited to lenders and venture capital investors, including other investors in our portfolio companies;
- the impact and timing of our unfunded commitments;
- the expected market for venture capital investments;
- the performance of our existing portfolio and other investments we may make in the future;
- the impact of investments that we expect to make;
- actual and potential conflicts of interest with TPC, the Adviser and its senior investment team and Investment Committee;
- our contractual arrangements and relationships with third parties;
- the dependence of our future success on the U.S. and global economies, including with respect to the industries in which we invest;
- our expected financings and investments;
- the ability of our Adviser to attract, retain and have access to highly talented professionals, including our Adviser’s senior management team;
- our ability to qualify and maintain our qualification as a RIC and as a BDC;
- the adequacy of our available liquidity, cash resources and working capital and compliance with covenants under our borrowing arrangements; and
- the timing of cash flows, if any, from the operations of our portfolio companies.

These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

- changes in laws and regulations, changes in political, economic or industry conditions, and changes in the interest rate environment or other conditions affecting the financial and capital markets, including with respect to changes resulting from or in response to, or potentially even the absence of changes as a result of, the impact of the Coronavirus (“COVID-19”) pandemic;
- the length and duration of the COVID-19 outbreak in the United States as well as worldwide, and the magnitude of its impact and time required for economic recovery, including with respect to the impact of travel restrictions and other isolation and quarantine measures on the ability of the Adviser’s investment professionals to conduct in-person diligence on, and otherwise monitor, existing and future investments;
- an economic downturn and the time period required for robust economic recovery therefrom, including relating to the impact of the COVID-19 pandemic, which has already generally had a material impact on our portfolio companies’ results of operations and financial condition and will likely continue to have a material impact on our portfolio companies’ results of operations and financial condition for its duration, which could lead to the loss of some or all of our investments in such portfolio companies and have a material adverse effect on our results of operations and financial condition;
- a contraction of available credit, an inability or unwillingness of our lenders to fund their commitments to us and/or an inability to access capital markets or additional sources of liquidity, including as a result of the impact and duration of the COVID-19 pandemic, could have a material adverse effect on our results of operations and financial condition and impair our lending and investment activities;
- interest rate volatility could adversely affect our results, particularly given that we use leverage as part of our investment strategy;
- currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars;
- risks associated with possible disruption in our or our portfolio companies’ operations due to wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics; and
- the risks, uncertainties and other factors we identify in “Risk Factors” in this Quarterly Report on Form 10-Q, in our most recent Annual Report on Form 10-K under Part I, Item 1A, and in our other filings with the SEC that we make from time to time.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include, without limitation, our ability to originate new loans and investments, borrowing costs and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q.

### Overview

We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. Our shares are currently listed on the New York Stock Exchange (the “NYSE”) under the symbol “TPVG”.

We were formed to expand the venture growth stage business segment of TPC’s investment platform. TPC is widely recognized as a leading global financing provider devoted to serving venture capital-backed companies with creative, flexible and customized debt financing, equity capital and complementary services throughout their lifespan. TPC is located on Sand Hill Road in Silicon Valley and has a primary focus in technology, life sciences and other high growth industries.

Our investment objective is to maximize our total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by lending primarily with warrants to venture growth stage companies focused in technology, life sciences and other high growth industries backed by TPC’s select group of leading venture capital investors.

### COVID-19 Developments

The COVID-19 pandemic, and the related effect on the U.S. and global economies, including the recent economic downturn and the uncertainty associated with the timing and likelihood of economic recovery, has had adverse consequences for the business operations of some of our portfolio companies and has adversely affected, and threatens to continue to adversely affect, our operations and the operations of the Adviser.

While we have been monitoring, and continue to monitor, the COVID-19 pandemic and its impact on our and our portfolio companies’ business, we have continued to raise capital, maintain appropriate levels of available liquidity, support and monitor our existing portfolio companies, fund existing unfunded commitments, and selectively deploy capital in new investment opportunities in venture growth stage companies. As a result of our focus on maintaining adequate liquidity amid current market uncertainty, our interest expense has modestly increased from comparable prior year periods due to maintaining a higher weighted average outstanding principal balance on borrowings and increased cash reserves.

We have seen, and may continue to see, certain of our portfolio companies experience financial distress and, depending on the duration of the COVID-19 pandemic and the extent of its disruption to operations, believe that there is an increased risk of certain of our portfolio companies defaulting on their financial obligations to us and their other capital providers. In addition, as a result of the adverse effects of the COVID-19 pandemic and the related disruption and financial distress, certain portfolio companies may seek to modify their loans from us, which could reduce the amount or extend the time for payment of principal, reduce the rate or extend the time of payment of interest, and/or increase the amount of PIK interest we receive with respect to such investment, among other things. The effects of the COVID-19 pandemic have also impeded, and may continue to impede, the ability of certain of our portfolio companies to raise additional capital and/or pursue asset sales or otherwise execute strategic transactions, which could have a material adverse effect on the valuation of our investments in such companies. Portfolio companies operating in certain industries may be more susceptible to these risks than other portfolio companies in other industries in light of the effects of the COVID-19 pandemic. Some of our portfolio companies have already taken steps to significantly reduce, modify, or alter business strategies and operations, and additional portfolio companies may take similar steps if subjected to prolonged and severe financial distress, which may impair their business on a permanent basis. In addition, due to the completion of equity rounds by certain portfolio companies at lower valuations than rounds completed prior to the onset of the COVID-19 pandemic, we have experienced unrealized depreciation on certain of our warrant and equity investments despite the relevant companies’ ability to mitigate disruptions on their business strategies and operations. There can be no assurance that future equity rounds completed by our portfolio companies will be at levels greater than or equal to previous rounds, which may result in net unrealized depreciation on our warrant and equity portfolio in future periods.

In part due to these COVID-19-related developments, the fair value of certain of our portfolio investments as of March 31, 2021 and our expected recoveries for certain investments have decreased as compared to their fair value and expected recoveries as of March 31, 2020 and December 31, 2019. As of March 31, 2021, we had one portfolio company in which our investments were on non-accrual status (which was generally caused by events unrelated to the COVID-19 pandemic), with an aggregate cost and fair value of $31.4 million and $22.0 million, respectively. The various effects of the COVID-19 pandemic, including those discussed above, increase the risk that we will place additional investments on non-accrual status in the future. Any significant increase in aggregate unrealized depreciation of our investment portfolio or significant reductions in our net asset value as a result of the effects of the COVID-19 pandemic or otherwise increases the risk of failing to meet the 1940 Act asset coverage requirements and breaching covenants under the Credit Facility, or under the governing agreements for the 2025 Notes and the 2026 Notes, or otherwise triggering an event of default under the relevant borrowing arrangement. Any such breach of covenant or event of default, if we are not able to obtain a waiver from the required lenders or debt holders, would have a material adverse effect on our business, liquidity, financial condition, results of operations and ability to pay distributions to our stockholders. See “Risk Factors” in this Quarterly Report on Form 10-Q and “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020 for more information. As of March 31, 2021, we were in compliance with the asset coverage requirements under the 1940 Act, and we were not in breach of any covenants under the Credit Facility or under the governing agreements for the 2022 Notes, the 2025 Notes or the 2026 Notes. We do not expect to breach any of these covenants in the near term assuming that conditions do not materially deteriorate further or for a prolonged period of time.

We will continue to monitor the evolving situation relating to the COVID-19 pandemic and related guidance from U.S. and international authorities, including federal, state and local public health authorities. Given the dynamic nature of this situation and the fact that there may be developments outside of our control that require us or our portfolio companies to adjust plans of operation, we cannot reasonably estimate the full impact of COVID-19 on our financial condition, results of operations or cash flows in the future. However, it could have a material adverse impact for a prolonged period of time on our future net investment income, particularly with respect to our interest income, the fair value of our portfolio investments, and the results of operations and financial condition of us and our portfolio companies. See “Risk Factors” in this Quarterly Report on Form 10-Q, and in our other filings with the SEC that we make from time to time, for more information.

### Portfolio Composition, Investment Activity and Asset Quality

#### Portfolio Composition

We originate and invest primarily in venture growth stage companies. Companies at the venture growth stage have distinct characteristics differentiating them from venture capital-backed companies at other stages in their development lifecycle. We invest primarily in (i) growth capital loans that have a secured collateral position and that are generally used by venture growth stage companies to finance their continued expansion and growth, (ii) equipment financings, which may be structured as loans or leases, that have a secured collateral position on specified mission-critical equipment, (iii) on a select basis, revolving loans that have a secured collateral position and that are typically used by venture growth stage companies to advance against inventory, components, accounts receivable, contractual or future billings, bookings, revenues, sales or cash payments and collections including proceeds from a sale, financing or the equivalent and (iv) direct equity investments in venture growth stage companies. In connection with our growth capital loans, equipment financings and revolving loans, we generally receive warrant investments that allow us to participate in any equity appreciation of our borrowers and enhance our overall investment returns.

As of March 31, 2021, we had 192 investments in 71 companies. Our investments included 84 debt investments, 78 warrant investments, and 30 direct equity and related investments. As of March 31, 2021, the aggregate cost and fair value of these investments were $643.7 million and $633.7 million, respectively. As of March 31, 2021, one of our portfolio companies was publicly traded. As of March 31, 2021, the 84 debt investments had an aggregate fair value of $574.1 million and a weighted average loan to enterprise value ratio at the time of underwriting of 8.9%. Enterprise value of a portfolio company is estimated based on information available, including any information regarding the most recent rounds of equity funding, at the time of origination.

As of December 31, 2020, we had 195 investments in 69 companies. Our investments included 94 debt investments, 75 warrant investments, and 26 direct equity and related investments. As of December 31, 2020, the aggregate cost and fair value of these investments were $662.4 million and $633.8 million, respectively. As of December 31, 2020, one of our portfolio companies was publicly traded. As of December 31, 2020, the 94 debt investments had an aggregate fair value of $583.3 million and a weighted average loan to enterprise value ratio at the time of underwriting of 8.9%. Enterprise value of a portfolio company is estimated based on information available, including any information regarding the most recent rounds of equity funding, at the time of origination.

The following tables show information on the cost and fair value of our investments in companies along with the number of companies in our portfolio as of March 31, 2021 and December 31, 2020:

| Investments by Type (dollars in thousands) | March 31, 2021 Cost | Fair Value | Net Unrealized Gains (losses) | Number of Investments | Number of Companies |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Debt investments | $590,592 | $574,131 | $(16,461) | 84 | 33 |  |
| Warrant investments | 21,902 | 29,789 | 7,887 | 78 | 67 |  |
| Equity investments | 31,196 | 29,776 | (1,420) | 30 | 27 |  |
| Total Investments in Portfolio Companies | $643,690 | $633,696 | $(9,994) | 192 | 71 | (1) |

(1) Represents non-duplicative number of companies.

| Investments by Type (dollars in thousands) | December 31, 2020 Cost | Fair Value | Net Unrealized Gains (losses) | Number of Investments | Number of Companies |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Debt investments | $613,345 | $583,335 | $(30,010) | 94 | 33 |  |
| Warrant investments | 20,525 | 24,231 | 3,706 | 75 | 64 |  |
| Equity investments | 28,553 | 26,213 | (2,340) | 26 | 24 |  |
| Total Investments in Portfolio Companies | $662,423 | $633,779 | $(28,644) | 195 | 69 | (1) |

(1) Represents non-duplicative number of companies.

The following tables show the fair value of the portfolio of investments, by industry and the percentage of the total investment portfolio, as of March 31, 2021 and December 31, 2020:

| Investments in Portfolio Companies by Industry (dollars in thousands) | March 31, 2021 At Fair Value | Percentage of Total Investments |
| --- | ---: | ---: |
| Business Applications Software | $72,342 | 11.4% |
| Financial Institution and Services | 58,155 | 9.2 |
| E-Commerce - Clothing and Accessories | 54,417 | 8.6 |
| Healthcare Technology Systems | 40,914 | 6.5 |
| Network Systems Management Software | 40,233 | 6.3 |
| Entertainment | 39,996 | 6.3 |
| Consumer Products and Services | 39,226 | 6.2 |
| Security Services | 31,632 | 5.0 |
| Household & Office Goods | 30,679 | 4.8 |
| Social/Platform Software | 30,656 | 4.8 |
| Travel & Leisure | 30,299 | 4.8 |
| Other Financial Services | 26,167 | 4.1 |
| Shopping Facilitators | 24,897 | 3.9 |
| Real Estate Services | 22,498 | 3.6 |
| Consumer Non-Durables | 22,208 | 3.5 |
| Food & Drug | 16,885 | 2.7 |
| Multimedia and Design Software | 15,292 | 2.4 |
| E-Commerce - Personal Goods | 14,554 | 2.3 |
| Commercial Services | 10,230 | 1.6 |
| Consumer Finance | 6,182 | 1.0 |
| Consumer Retail | 2,157 | 0.3 |
| Communications Software | 2,000 | 0.3 |
| General Media and Content | 1,092 | 0.2 |
| Educational/Training Software | 441 | 0.1 |
| Business to Business Marketplace | 236 | \* |
| Conferencing Equipment / Services | 205 | \* |
| Transportation | 55 | \* |
| Building Materials/Construction Machinery | 35 | \* |
| Advertising / Marketing | 13 | \* |
| Medical Software and Information Services | — | \* |
| Total portfolio company investments | $633,696 | 100.0% |

\* Amount represents less than 0.05% of the total portfolio investments.

| Investments in Portfolio Companies by Industry (dollars in thousands) | December 31, 2020 At Fair Value | Percentage of Total Investments |
| --- | ---: | ---: |
| Business Applications Software | $74,623 | 11.8% |
| E-Commerce - Clothing and Accessories | 54,678 | 8.6 |
| Healthcare Technology Systems | 42,120 | 6.6 |
| Consumer Products and Services | 40,730 | 6.4 |
| Network Systems Management Software | 39,859 | 6.3 |
| Financial Institution and Services | 39,037 | 6.2 |
| Entertainment | 38,636 | 6.1 |
| Consumer Non-Durables | 33,384 | 5.3 |
| Security Services | 30,459 | 4.8 |
| Household & Office Goods | 30,447 | 4.8 |
| Social/Platform Software | 30,412 | 4.8 |
| Travel & Leisure | 30,028 | 4.7 |
| Shopping Facilitators | 24,833 | 3.9 |
| Real Estate Services | 23,887 | 3.8 |
| Other Financial Services | 19,198 | 3.0 |
| Food & Drug | 15,720 | 2.5 |
| Multimedia and Design Software | 15,082 | 2.4 |
| Buildings and Property | 15,000 | 2.4 |
| E-Commerce - Personal Goods | 13,892 | 2.2 |
| Commercial Services | 10,181 | 1.6 |
| Consumer Finance | 6,150 | 1.0 |
| Communications Software | 2,000 | 0.3 |
| Consumer Retail | 1,346 | 0.2 |
| General Media and Content | 1,092 | 0.2 |
| Educational/Training Software | 441 | 0.1 |
| Conferencing Equipment / Services | 205 | \* |
| Business to Business Marketplace | 200 | \* |
| Building Materials/Construction Machinery | 71 | \* |
| Transportation | 55 | \* |
| Advertising / Marketing | 13 | \* |
| Medical Software and Information Services | — | — |
| Total portfolio company investments | $633,779 | 100.0% |

\* Amount represents less than 0.05% of the total portfolio investments.

The following table shows the financing product type of our debt investments as of March 31, 2021 and December 31, 2020:

| Debt Investments By Financing Product (dollars in thousands) | March 31, 2021 Fair Value | Percentage of Total Debt Investments | December 31, 2020 Fair Value | Percentage of Total Debt Investments |
| --- | ---: | ---: | ---: | ---: |
| Growth capital loans | $565,307 | 98.4% | $574,414 | 98.4% |
| Revolver loans | 8,529 | 1.5 | 8,627 | 1.5 |
| Convertible notes | 295 | 0.1 | 294 | 0.1 |
| Total debt investments | $574,131 | 100.0% | $583,335 | 100.0% |

Growth capital loans in which the borrower held a term loan facility, with or without an accompanying revolving loan, in priority to our senior lien represent 28.7% and 30.6% of our debt investments at fair value as of March 31, 2021 and December 31, 2020, respectively.

#### Investment Activity

During the three months ended March 31, 2021, we entered into debt commitments with four new portfolio companies and three existing portfolio companies totaling $90.4 million, funded nine debt investments for $56.9 million in principal value, acquired warrant investments representing $1.6 million of value, and made equity investments of $2.3 million. Debt investments funded during the three months ended March 31, 2021 carried a weighted average annualized portfolio yield of 12.6% at origination.

During the three months ended March 31, 2020, we entered into debt commitments with three new portfolio companies and four existing portfolio companies totaling $102.6 million, funded 17 debt investments for $78.8 million in principal value, acquired warrant investments representing $1.1 million of value and made equity investments of $1.4 million.

During the three months ended March 31, 2021, we received $36.0 million of principal prepayments and $15.1 million of scheduled principal amortization.

During the three months ended March 31, 2020, we received $1.0 million of debt prepayments and $5.8 million of scheduled amortization and repayments.

The following table shows the total portfolio investment activity for the three months ended March 31, 2021 and 2020 was as follows:

*(in thousands)*

|  | For the Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Beginning portfolio at fair value | $633,779 | $653,129 |
| New debt investments, net(1) | 55,642 | 77,025 |
| Scheduled principal amortization | (15,069) | (5,813) |
| Principal prepayments and early repayments | (35,966) | (1,000) |
| Accretion of debt investment fees | 1,119 | 3,782 |
| Payment-in-kind coupon | 1,981 | 852 |
| New warrant investments | 1,621 | 1,074 |
| New equity investments | 2,643 | 1,420 |
| Proceeds from dispositions of investments | (15,000) | — |
| Net realized gains (losses) on investments | (15,703) | (289) |
| Net unrealized gains (losses) on investments | 18,649 | (17,025) |
| Ending portfolio at fair value | $633,696 | $713,155 |

(1) Debt balance is net of fees and discounts applied to the loan at origination.

As of March 31, 2021, our unfunded commitments to 18 companies totaled $168.8 million. During the three months ended March 31, 2021, $15.0 million in unfunded commitments expired or were terminated.

As of December 31, 2020, our unfunded commitments to 16 companies totaled $132.3 million. During the year ended December 31, 2020, $160.7 million in unfunded commitments expired or were terminated.

The following table shows additional information on our unfunded commitments regarding milestones, expirations, and types of loans as of March 31, 2021 and December 31, 2020:

| Unfunded Commitments(1) (in thousands) | March 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Dependent on milestones | $35,250 | $17,500 |
| Expiring during: |  |  |
| 2021 | $121,750 | $122,250 |
| 2022 | 44,032 | 7,000 |
| 2024 | 3,000 | 3,000 |
| Total | $168,782 | $132,250 |

(1) Does not include backlog of potential future commitments.

Our credit agreements contain customary lending provisions that allow us relief from funding obligations for previously made commitments in instances where the underlying company experiences material adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for us. We generally expect 50% - 75% of our gross unfunded commitments to eventually be drawn before the expiration of their corresponding availability periods.

The fair value at the inception of the delay draw credit agreements with our portfolio companies is equal to the fees and/or warrants received to enter into these agreements, taking into account the remaining terms of the agreements and the relevant counterparty’s credit profile. The unfunded commitment liability reflects the fair value of these future funding commitments. As of March 31, 2021 and December 31, 2020, the fair value for these unfunded commitments totaled $2.4 million and $1.7 million, respectively, and was included in “other accrued expenses and liabilities” in our consolidated statements of assets and liabilities.

Our level of investment activity can vary substantially from period to period as our Adviser chooses to slow or accelerate new business originations depending on market conditions, rate of investment of TPC’s select group of leading venture capital investors, our Adviser’s knowledge, expertise and experience, our funding capacity (including availability under the Credit Facility and our ability or inability to raise equity or debt capital), and other market dynamics.

The following table shows the debt commitments, fundings of debt investments (principal balance) and equity investments and non-binding term sheet activity for the three months ended March 31, 2021 and 2020:

| Commitments and Fundings (in thousands) 2021 Debt Commitments | For the Three Months Ended March 31, 2020 |  |
| --- | ---: | ---: |
| New portfolio companies | $57,179 | $65,000 |
| Existing portfolio companies | 33,219 | 37,573 |
| Total(1) | $90,398 | $102,573 |
| **Funded Debt Investments** | $56,908 | $78,761 |
| **Equity Investments** | $2,335 | $1,420 |
| **Non-Binding Term Sheets** | $192,172 | $79,530 |

(1) Includes backlog of potential future commitments.

We may enter into commitments with certain portfolio companies that permit an increase in the commitment amount in the future in the event that conditions to such increases are met (“backlog of potential future commitments”). If such conditions to increase are met, these amounts may become unfunded commitments if not drawn prior to expiration. As of March 31, 2021 and December 31, 2020, this backlog of potential future commitments totaled $2.5 million and $20.8 million, respectively.

#### Asset Quality

Consistent with TPC’s existing policies, our Adviser maintains a credit watch list which places borrowers into five risk categories based on our Adviser’s senior investment team’s judgment, where 1 is the highest rating and all new loans are generally assigned a rating of 2.

| Category | Category Definition | Action Item |
| --- | --- | --- |
| **Clear (1)** | Performing above expectations and/or strong financial or enterprise profile, value or coverage. | Review quarterly. |
| **White (2)** | Performing at expectations and/or reasonably close to it. Reasonable financial or enterprise profile, value or coverage. Generally, all new loans are initially graded White. | Contact portfolio company periodically; in no event less than quarterly. |
| **Yellow (3)** | Performing generally below expectations and/or some proactive concern. Adequate financial or enterprise profile, value or coverage. | Contact portfolio company monthly or more frequently as determined by our Adviser’s Investment Committee; contact venture capital investors. |
| **Orange (4)** | Needs close attention due to performance materially below expectations, weak financial and/or enterprise profile, concern regarding additional capital or exit equivalent. | Contact portfolio company weekly or more frequently as determined by our Adviser’s Investment Committee; contact venture capital investors regularly; our Adviser forms a workout group to minimize risk of loss. |
| **Red (5)** | Serious concern/trouble due to pending or actual default or equivalent. May experience partial and/or full loss. | Maximize value from assets. |

The following table shows the credit rankings for the portfolio companies that had outstanding debt obligations to us as of March 31, 2021 and December 31, 2020:

| Credit Category (dollars in thousands) | March 31, 2021 Fair Value | Percentage of Total Debt Investments | Number of Portfolio Companies | December 31, 2020 Fair Value | Percentage of Total Debt Investments | Number of Portfolio Companies |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Clear (1) | $44,607 | 7.8% | 3 | $74,276 | 12.7% | 5 |
| White (2) | 442,224 | 77.0 | 27 | 413,193 | 70.8 | 24 |
| Yellow (3) | 65,342 | 11.4 | 2 | 59,489 | 10.2 | 2 |
| Orange (4) | 21,958 | 3.8 | 1 | 21,377 | 3.7 | 1 |
| Red (5) | — | — | — | 15,000 | 2.6 | 1 |
|  | $574,131 | 100.0% | 33 | $583,335 | 100.0% | 33 |

As of March 31, 2021 and December 31, 2020, the weighted average investment ranking of our debt investment portfolio was 2.11 and 2.13, respectively. During the three months ended March 31, 2021, portfolio company credit category changes, excluding fundings and repayments, consisted of the following: one portfolio company with a principal balance of $25.0 million was removed from Clear (1) due to prepayment, and one portfolio company investment with a principal balance of $29.5 million was sold and removed from Red (5) and from our investment portfolio.

### Results of Operations

#### Comparison of operating results for the three months ended March 31, 2021 and 2020

An important measure of our financial performance is net increase (decrease) in net assets resulting from operations, which includes net investment income (loss), net realized gains (losses) and net unrealized gains (losses). Net investment income (loss) is the difference between our income from interest, dividends, fees and other investment income and our operating expenses including interest on borrowed funds. Net realized gains (losses) on investments is the difference between the proceeds received from dispositions of portfolio investments and their amortized cost. Net unrealized gains (losses) on investments is the net change in the fair value of our investment portfolio.

For the three months ended March 31, 2021, our net increase in net assets resulting from operations was $11.9 million, which was comprised of $8.9 million of net investment income and $3.0 million of net realized and unrealized gains. On a per share basis for the three months ended March 31, 2021, net investment income was $0.29 per share and the net increase in net assets from operations was $0.38 per share.

For the three months ended March 31, 2020, our net decrease in net assets resulting from operations was $5.1 million, which was comprised of $12.2 million of net investment income and $17.4 million of net realized and unrealized losses. On a per share basis for the three months ended March 31, 2020, net investment income was $0.41 per share and the net decrease in net assets from operations was $0.17 per share.

#### Investment Income

For the three months ended March 31, 2021, total investment and other income was $20.0 million as compared to $20.8 million for the three months ended March 31, 2020. The decrease in total investment and other income for the three months ended March 31, 2021, compared to the 2020 period, is primarily due to lower weighted average principal outstanding on our income-bearing debt investment portfolio, partially offset by greater prepayment activity.

For the three months ended March 31, 2021, we recognized $0.8 million in other income consisting of $0.3 million from the termination or expiration of unfunded commitments, and $0.5 million from the realization of certain fees paid and accrued from portfolio companies and other income related to prepayment activity. For the three months ended March 31, 2020, we recognized $0.6 million in other income, consisting primarily of $0.5 million from the termination or expiration of unfunded commitments.

#### Operating Expenses

Total operating expenses consist of base management fee, income incentive fee, capital gains incentive fee, interest expense and amortization of fees, administration agreement expenses, and general and administrative expenses. In determining the base management fee, our Adviser has agreed to exclude U.S. Treasury bill assets acquired at the end of each applicable quarter from the calculation of the gross assets. We anticipate operating expenses will increase over time as our portfolio continues to grow. However, we anticipate operating expenses, as a percentage of totals assets and net assets, will generally decrease over time as our portfolio and capital base expand. We expect base management and income incentive fees will increase as we grow our asset base and our earnings. The capital gains incentive fee will depend on realized and unrealized gains and losses. Interest expenses will generally increase as we utilize more of the Credit Facility and issue additional debt securities, and we generally expect expenses under the administration agreement and general and administrative expenses to increase over time to meet the additional requirements associated with servicing a larger portfolio.

For the three months ended March 31, 2021, total operating expenses were $11.1 million as compared to $8.6 million for the three months ended March 31, 2020.

Base management fees totaled $2.9 million and $2.8 million for the three months ended March 31, 2021 and 2020, respectively. Base management fees for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, increased primarily due to an increase in the average size of our portfolio during the applicable periods used in the calculation.

Income incentive fees totaled $2.2 million for the three months ended March 31, 2021. For the three months ended March 31, 2020, our income incentive fee was reduced by $2.4 million due to the total return requirement under the income component of our incentive fee structure, which resulted in a corresponding increase of approximately $2.4 million in net investment income.

There was no capital gains incentive fee expense calculated for the three months ended March 31, 2021 and 2020.

For the three months ended March 31, 2021 and 2020, interest and fees on our borrowings totaled $4.4 million and $4.2 million, respectively. Interest and fee expenses for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, increased due to the issuance of the 2026 Notes, partially offset by a lower weighted-average outstanding principal balance under our Credit Facility.

Administration agreement and general and administrative expenses totaled $1.6 million and $1.7 million for the three months ended March 31, 2021 and three months ended March 31, 2020, respectively. The slight decrease for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, was primarily due to a lower allocation of administration expenses under the Administration Agreement.

#### Net Realized Gains and Losses and Net Unrealized Gains and Losses

Realized gains and losses are included in “net realized gains (losses) on investments” in the consolidated statements of operations.

During the three months ended March 31, 2021, we recognized net realized losses on investments of $15.7 million consisting primarily of the sale of our investment in Knotel, Inc., which was rated Red (5) on our credit watch list, and its removal from our investment portfolio.

During the three months ended March 31, 2020, we recognized net realized losses on investments of $0.3 million, primarily as a result of the termination of warrants in one portfolio company.

Unrealized gains and losses are included in “net change in unrealized gains (losses) on investments” in the consolidated statements of operations.

Net change in unrealized gains during the three months ended March 31, 2021 was $18.6 million, resulting primarily from the reversal and recognition of $15.6 million of previously recorded unrealized losses associated with Knotel, Inc., as well as net unrealized gains on our investment portfolio resulting from fair value adjustments, partially offset by $1.4 million of unrealized losses due to changes in foreign currency.

Net change in unrealized losses during the three months ended March 31, 2020 was $17.0 million, resulting primarily from mark-to-market related changes, as well as credit-related adjustments.

Net change in realized and unrealized gains or losses in subsequent periods may be volatile as such results depend on changes in the market, changes in the underlying performance of our portfolio companies and their respective industries, and other market factors.

#### Portfolio Yield and Total Return

Investment income includes interest income on our debt investments utilizing the effective yield method including cash interest income as well as the amortization of any purchase premium, accretion of purchase discount, original issue discount, facilities fees, and the amortization and payment of the end-of-term (“EOT”) payments. For the three months ended March 31, 2021 and 2020, interest income totaled $19.2 million and $20.3 million, respectively, representing a weighted average annualized portfolio yield on total debt investments for the period held of 13.3% and 12.7%, respectively.

We calculate weighted average annualized portfolio yields for periods shown as the annualized rates of the interest income recognized during the period divided by the average amortized cost of debt investments in the portfolio during the period. The weighted average yields reported for these periods are annualized and reflect the weighted average yields to maturities. Should the portfolio companies choose to repay their loans earlier, our weighted average yields will increase for those debt investments affected but may reduce our weighted average yields on the remaining portfolio in future quarters.

The yield on our total debt portfolio, excluding the impact of prepayments, was 11.9% and 12.7% for the three months ended March 31, 2021 and 2020, respectively.

The following table shows the weighted average annualized portfolio yield on our total debt portfolio comprising of cash interest income, accretion of the net purchase discount, facilities fees and the value of warrant investments received, accretion of EOT payments and the accelerated receipt of EOT payments on prepayments:

| Ratios (Percentages, on an annualized basis)(1) 2021 | For the Three Months Ended March 31, 2020 |  |
| --- | ---: | ---: |
| Weighted average annualized portfolio yield on total debt investments(2) | 13.3% | 12.7% |
| Coupon income | 9.7% | 9.8% |
| Accretion of discount | 0.9% | 1.2% |
| Accretion of end-of-term payments | 1.3% | 1.7% |
| Impact of prepayments during the period | 1.4% | —% |

(1) Weighted average portfolio yields on total debt investments for periods shown are the annualized rates of interest income recognized during the period divided by the average amortized cost of debt investments in the portfolio during the period.

(2) The weighted average portfolio yields on total debt investments reflected above do not represent actual investment returns to our stockholders.

Our weighted average annualized portfolio yield on debt investments may be higher than an investor’s yield on an investment in shares of our common stock. Our weighted average annualized portfolio yield on debt investments does not reflect operating expenses that may be incurred by us and, thus, by our stockholders. In addition, our weighted average annualized portfolio yield on debt investments and total return figures disclosed in this Quarterly Report on Form 10-Q do not consider the effect of any sales commissions or charges that may be incurred in connection with the sale of shares of our common stock. Our weighted average annualized portfolio yield on debt investments and total return figures do not represent actual investment returns to stockholders. Our weighted average annualized portfolio yield on debt investments and total return figures are subject to change and, in the future, may be greater or less than the rates in this Quarterly Report on Form 10-Q. Total return based on NAV is the change in ending NAV per share plus distributions per share paid during the period assuming participation in our dividend reinvestment plan divided by the beginning NAV per share for such period. Total return based on stock price is the change in the ending stock price of our common stock plus distributions paid during the period assuming participation in our dividend reinvestment plan divided by the beginning stock price of our common stock for such period.

For the three months ended March 31, 2021 and 2020 our total return during the period based on the change in NAV plus distributions reinvested as of the respective distribution dates was 3.6% and 2.4%, respectively, and our total return during the period based on the change in stock price plus distributions reinvested as of the respective distribution dates was 14.6% and (57.1)%, respectively. These total return figures are for the periods shown and are not annualized.

The table below shows our return on average total assets and return on average NAV for the three months ended March 31, 2021 and 2020:

| Returns on Net Asset Value and Total Assets (dollars in thousands) 2021 | For the Three Months Ended March 31, 2020 |  |
| --- | ---: | ---: |
| Net investment income | $8,907 | $12,237 |
| Net increase (decrease) in net assets | $11,859 | $(5,118) |
| Average net asset value(1) | $402,043 | $404,355 |
| Average total assets(1) | $695,203 | $724,389 |
| Net investment income to average net asset value(2) | 9.0% | 12.2% |
| Net increase (decrease) in net assets to average net asset value(2) | 12.0% | (5.1)% |
| Net investment income to average total assets(2) | 5.2% | 6.8% |
| Net increase (decrease) in net assets to average total assets(2) | 6.9% | (2.8)% |

(1) The average net asset values and the average total assets are computed based on daily balances.

(2) Percentage is presented on an annualized basis.

### Critical Accounting Policies

The preparation of our consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates, including with respect to the valuation of our investments, could cause actual results to differ.

Understanding our accounting policies and the extent to which we use management’s judgment and estimates in applying these policies is integral to understanding our financial statements. We describe our most significant accounting policies in “Note 2. Significant Accounting Policies” in our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in this Quarterly Report on Form 10-Q. Critical accounting policies are those that require the application of management’s most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods. Management has utilized available information, including our past history, industry standards and the current economic environment, among other factors, in forming the estimates and judgments, giving due consideration to materiality. We have identified the valuation of our investment portfolio, including our investment valuation policy (which has been approved by the Board), as our critical accounting policy and estimates. The critical accounting policies should be read in conjunction with our risk factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in this Quarterly Report on Form 10-Q.

#### Investment Valuation

Investment transactions are recorded on a trade-date basis. Our investments are carried at fair value in accordance with the 1940 Act and ASC Topic 946 and measured in accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or “ASC Topic 820,” issued by the FASB. ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is a market-based measure considered from the perspective of the market’s participant who holds the financial instrument rather than an entity-specific measure. When market assumptions are not readily available, our own assumptions are set to reflect those that the Adviser believes market participants would use in pricing the financial instruments on the measurement date.

The availability of observable inputs can vary depending on the financial instrument and is affected by a variety of factors. To the extent the valuation is based on models or inputs that are less observable, the determination of fair value requires more judgment. Our valuation methodology is approved by the Board, and the Board is responsible for the fair values determined. As markets change, new types of investments are made, or pricing for certain investments becomes more or less observable, management, with oversight from the Board, may refine our valuation methodologies to best reflect the fair value of our investments appropriately.

As of March 31, 2021, our investment portfolio, valued at fair value in accordance with our Board-approved valuation policy, represented approximately 83.9% of our total assets, as compared to approximately 92.7% of our total assets as of December 31, 2020.

See “Note 4. Investments” in the notes to consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC on March 3, 2021 and under “Note 4. Investments” in the notes to consolidated financial statements included in this Quarterly Report on Form 10-Q for more information on our valuation process.

### Liquidity and Capital Resources

We believe that our current cash and cash equivalents on hand, our available borrowing capacity under the Credit Facility and our anticipated cash flows from operations, including from contractual monthly portfolio company payments and cash flows, prepayments, and the ability to liquidate publicly traded investments, will be adequate to meet our cash needs for our daily operations. This “Liquidity and Capital Resources” section should be read in conjunction with “COVID-19 Developments” above and the risk factors discussed below in this Quarterly Report on Form 10-Q.

#### Cash Flows

During the three months ended March 31, 2021, net cash provided by operating activities, consisting primarily of purchases, sales and repayments of investments and the items described in “Results of Operations,” was $5.4 million, and net cash provided by financing activities was $66.1 million due to the issuance of the 2026 Notes, partially offset by net repayments under the Credit Facility of $118.0 million, and $13.6 million in distributions paid. As of March 31, 2021, cash and cash equivalents, including restricted cash, was $116.1 million.

During the three months ended March 31, 2020, net cash used by operating activities, consisting primarily of purchases, sales and repayments of investments and the items described in “Results of Operations,” was $72.2 million and net cash provided by financing activities was $131.4 million due to net proceeds received from our January 2020 public follow-on offering of common stock and the issuance of the 2025 Notes in March 2020, partially offset by net repayments under the Credit Facility of $5.3 million and $10.6 million in distributions paid. As of March 31, 2020, cash and cash equivalents, including restricted cash, was $85.6 million.

#### Capital Resources and Borrowings

As a BDC, we generally have an ongoing need to raise additional capital for investment purposes. As a result, we expect, from time to time, to access the debt and equity markets when we believe it is necessary and appropriate to do so. In this regard, we continue to explore various options for obtaining additional debt or equity capital for investments. This may include expanding or extending the Credit Facility or the issuance of additional shares of our common stock or debt securities. If we are unable to obtain leverage or raise equity capital on terms that are acceptable to us, our ability to grow our portfolio could be substantially impacted.

#### Credit Facility

As of March 31, 2021, we had $350 million in total commitments available under the Credit Facility, subject to various covenants and borrowing base requirements. The Credit Facility also includes an accordion feature, which allows us to increase the size of the Credit Facility to up to $400 million under certain circumstances. The revolving period under the Credit Facility expires on November 30, 2022, and the maturity date of the Credit Facility is May 31, 2024 (unless otherwise terminated earlier pursuant to its terms). Borrowings under the Credit Facility bear interest at the sum of (i) a floating rate based on certain indices, including LIBOR and commercial paper rates (subject to a floor of 0.50%), plus (ii) a margin of 2.80% if facility utilization is greater than or equal to 75%, 2.90% if utilization is greater than or equal to 50%, 3.00% if utilization is less than 50% and 4.5% during the amortization period. See “Note 6. Borrowings” in the notes to consolidated financial statements for more information regarding the terms of the Credit Facility.

As of March 31, 2021 there were no outstanding borrowings under the Credit Facility and $2.9 million of deferred credit facility costs, which is included in the consolidated statements of assets and liabilities. As of December 31, 2020, we had outstanding borrowings of $118.0 million under the Credit Facility, excluding deferred credit facility costs of $3.2 million, which is included in the consolidated statements of assets and liabilities. We had $350.0 million and $207.0 million of remaining capacity on our Credit Facility as of March 31, 2021 and December 31, 2020, respectively.

#### 2022 Notes

On July 14, 2017, we completed a public offering of $65.0 million in aggregate principal amount of the 2022 Notes and received net proceeds of $62.8 million, after the payment of fees and offering costs. On July 24, 2017, as a result of the underwriters’ full exercise of their option to purchase additional 2022 Notes, we issued an additional $9.75 million in aggregate principal amount of the 2022 Notes and received net proceeds of $9.5 million, after the payment of fees and offering costs. The interest on the 2022 Notes, which accrues at an annual rate of 5.75%, is payable quarterly on January 15, April 15, July 15 and October 15. The maturity date of the 2022 Notes is July 15, 2022.

As of March 31, 2021 and December 31, 2020, we have recorded in the consolidated statements of assets and liabilities our liability for the 2022 Notes, net of deferred issuance costs, of $74.1 million and $74.0 million, respectively. See “Note 6. Borrowings” in the notes to consolidated financial statements for more information regarding the 2022 Notes.

As discussed under “Recent Developments” below, the entire $74.75 million aggregate principal amount of 2022 Notes was redeemed in full on April 5, 2021 in accordance with the terms of the indenture governing the 2022 Notes. In connection with the redemption, the 2022 Notes were delisted from the New York Stock Exchange.

On March 19, 2020, we completed a private offering of $70.0 million in aggregate principal amount of the 2025 Notes and received net proceeds of $69.1 million, after the payment of fees and offering costs. The interest on the 2025 Notes, which accrues at an annual rate of 4.50%, is payable semiannually on March 19 and September 19 each year. The maturity date of the 2025 Notes is scheduled for March 19, 2025.

As of March 31, 2021 and December 31, 2020, we have recorded in the consolidated statements of assets and liabilities our liability for the 2025 Notes, net of deferred issuance costs, of $69.2 million and $69.1 million, respectively. See “Note 6. Borrowings” in the notes to consolidated financial statements for more information regarding the 2025 Notes.

On March 1, 2021, we completed a private offering of $200.0 million in aggregate principal amount of the 2026 Notes and received net proceeds of $197.9 million, after the payment of fees and offering costs. The interest on the 2026 Notes, which accrues at an annual rate of 4.50%, is payable semiannually on March 19 and September 19 each year, beginning on September 19, 2021. The maturity date of the 2026 Notes is scheduled for March 1, 2026.

As of March 31, 2021, we have recorded in the consolidated statements of assets and liabilities our liability for the 2026 Notes, net of deferred issuance costs, of $197.9 million. See “Note 6. Borrowings” in the notes to consolidated financial statements for more information regarding the 2026 Notes.

#### Asset Coverage Requirements

On June 21, 2018, our stockholders voted at a special meeting of stockholders to approve a proposal to authorize us to be subject to a reduced asset coverage ratio of at least 150% under the 1940 Act. As a result of the stockholder approval at the special meeting, effective June 22, 2018, our applicable minimum asset coverage ratio under the 1940 Act has been decreased to 150% from 200%. Thus, we are permitted under the 1940 Act, under specified conditions, to issue multiple classes of debt and one class of stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after each such issuance. As of March 31, 2021, our asset coverage for borrowed amounts was 217%.

#### Contractual Obligations

The following table shows a summary of our payment obligations for repayment of debt as of March 31, 2021:

| Payments Due By Period (in thousands) Total | March 31, 2021 Less than 1 year | 1-3 years | 3-5 years | More than 5 years |  |
| --- | ---: | ---: | ---: | ---: | ---: |
| Credit Facility | $— | $— | $— | $— | $— |
| 2022 Notes | 74,750 | — | 74,750 | — | — |
| 2025 Notes | 70,000 | — | — | 70,000 | — |
| 2026 Notes | 200,000 | — | — | 200,000 | — |
| Total | $344,750 | $— | $74,750 | $270,000 | $— |

#### Off-Balance Sheet Arrangements

#### Commitments

We are a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of March 31, 2021 and December 31, 2020, our unfunded commitments totaled $168.8 million and $132.3 million, respectively, of which $35.3 million and $17.5 million, respectively, was dependent upon the portfolio companies reaching certain milestones before the debt commitment becomes available to them. Our credit agreements contain customary lending provisions that allow us relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences material adverse events that affect the financial condition or business outlook for the portfolio company.

The following table shows our unfunded commitments by portfolio company as of March 31, 2021 and December 31, 2020:

| Unfunded Commitments(1) (in thousands) | March 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Tempo Interactive Inc. | $25,000 | $— |
| Farmer's Business Network, Inc. | 20,000 | 20,000 |
| HomeLight, Inc. | 14,000 | 14,000 |
| DialPad, Inc. | 12,000 | 5,000 |
| Savage X, Inc. | 11,500 | 4,000 |
| Grove Collaborative, Inc. | 11,000 | 11,000 |
| OfferUp Inc. | 10,000 | 10,000 |
| Grey Orange International Inc. | 10,000 | — |
| Activehours, Inc. | 9,000 | 9,000 |
| Curology, Inc. | 9,000 | 9,000 |
| Narvar, Inc. | 7,500 | 3,750 |
| TFG Holding, Inc. | 7,000 | 7,000 |
| VanMoof Global Holding B.V. | 6,282 | — |
| Imperfect Foods, Inc. | 6,000 | 6,000 |
| Sonder USA, Inc. | 3,000 | 3,000 |
| Clutter Inc. | 3,000 | 9,000 |
| Hello Digit, Inc. | 2,500 | 2,500 |
| Envoy, Inc. | 2,000 | 4,000 |
| Capsule Corporation | — | 15,000 |
| **Total** | **$168,782** | **$132,250** |

(1) Does not include backlog of potential future commitments. Refer to “Investment Activity” above.

#### Distributions

We have elected to be treated, and intend to qualify annually, as a RIC under the Code. To obtain and maintain RIC tax treatment, we must distribute at least 90% of our net ordinary income and net realized short-term capital gains in excess of our net realized long-term capital losses, if any, to our stockholders. In order to avoid a non-deductible 4% U.S. federal excise tax on certain of our undistributed income, we would need to distribute during each calendar year an amount at least equal to the sum of: (a) 98% of our ordinary income (not taking into account any capital gains or losses) for such calendar year; (b) 98.2% of the amount by which our capital gains exceed our capital losses (adjusted for certain ordinary losses) for a one-year period ending on October 31 of the calendar year (unless an election is made by us to use our taxable year); and (c) certain undistributed amounts from previous years on which we paid no U.S. federal income tax. For the tax years ended December 31, 2020 and 2019, we were subject to a 4% U.S. federal excise tax and we may be subject to this tax in future years. In such cases, we will be liable for the tax only on the amount by which we do not meet the foregoing distribution requirement.

To the extent our taxable earnings fall below the total amount of our distributions for the year, a portion of those distributions may be deemed a return of capital to our stockholders. Our Adviser monitors available taxable earnings, including net investment income and realized capital gains, to determine if a return of capital may occur for the year. We estimate the source of our distributions as required by Section 19(a) of the 1940 Act to determine whether payment of dividends are expected to be paid from any other source other than net investment income accrued for current period or certain cumulative periods, but we will not be able to determine whether any specific distribution will be treated as made out of our taxable earnings or as a return of capital until after the end of our taxable year. Any amount treated as a return of capital will reduce a stockholder’s adjusted tax basis in his or her common stock, thereby increasing his or her potential gain or reducing his or her potential loss on the subsequent sale or other disposition of his or her common stock. On a quarterly basis, for any payment of dividends estimated to be paid from any other source other than net investment income accrued for current period or certain cumulative periods based on the Section 19(a) requirement, we post a Section 19(a) notice through the Depository Trust Company’s Legal Notice System and our website, as well as send our registered stockholders a printed copy of such notice along with the dividend payment. The estimates of the source of the distribution are interim estimates based on GAAP that are subject to revision, and the exact character of the distributions for tax purposes cannot be determined until the final books and records are finalized for the calendar year. Therefore, these estimates are made solely in order to comply with the requirements of Section 19(a) of the 1940 Act and should not be relied upon for tax reporting or any other purposes and could differ significantly from the actual character of distributions for tax purposes.

The following table shows our cash distributions per share that have been authorized by our Board since our initial public offering to March 31, 2021. From March 5, 2014 (commencement of operations) to December 31, 2015, and during the years ended December 31, 2017 and December 31, 2018, distributions represent ordinary income as our earnings exceeded distributions. Approximately $0.24 per share of the distributions during the year ended December 31, 2016 represented a return of capital. During the years ended December 31, 2019 and 2020, distributions represent ordinary income and long term capital gains. Depending on the duration of the COVID-19 pandemic and the extent of its impact on our portfolio companies’ operations and our net investment income, any future distributions to our stockholders may be for amounts less than our historical distributions, may be made less frequently than historical practices, and may be made in part cash and part stock (as per each stockholder’s election), subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution.

| Period Ended | Date Declared | Record Date | Payment Date | Per Share Amount |  |
| --- | --- | --- | --- | ---: | ---: |
| March 31, 2014 | April 3, 2014 | April 15, 2014 | April 30, 2014 | $0.09 | (1) |
| June 30, 2014 | May 13, 2014 | May 30, 2014 | June 17, 2014 | 0.30 |  |
| September 30, 2014 | August 11, 2014 | August 29, 2014 | September 16, 2014 | 0.32 |  |
| December 31, 2014 | October 27, 2014 | November 28, 2014 | December 16, 2014 | 0.36 |  |
| December 31, 2014 | December 3, 2014 | December 22, 2014 | December 31, 2014 | 0.15 | (2) |
| March 31, 2015 | March 16, 2015 | March 26, 2015 | April 16, 2015 | 0.36 |  |
| June 30, 2015 | May 6, 2015 | May 29, 2015 | June 16, 2015 | 0.36 |  |
| September 30, 2015 | August 11, 2015 | August 31, 2015 | September 16, 2015 | 0.36 |  |
| December 31, 2015 | November 10, 2015 | November 30, 2015 | December 16, 2015 | 0.36 |  |
| March 31, 2016 | March 14, 2016 | March 31, 2016 | April 15, 2016 | 0.36 |  |
| June 30, 2016 | May 9, 2016 | May 31, 2016 | June 16, 2016 | 0.36 |  |
| September 30, 2016 | August 8, 2016 | August 31, 2016 | September 16, 2016 | 0.36 |  |
| December 31, 2016 | November 7, 2016 | November 30, 2016 | December 16, 2016 | 0.36 |  |
| March 31, 2017 | March 13, 2017 | March 31, 2017 | April 17, 2017 | 0.36 |  |
| June 30, 2017 | May 9, 2017 | May 31, 2017 | June 16, 2017 | 0.36 |  |
| September 30, 2017 | August 8, 2017 | August 31, 2017 | September 15, 2017 | 0.36 |  |
| December 31, 2017 | November 6, 2017 | November 17, 2017 | December 1, 2017 | 0.36 |  |
| March 31, 2018 | March 12, 2018 | March 23, 2018 | April 6, 2018 | 0.36 |  |
| June 30, 2018 | May 2, 2018 | May 31, 2018 | June 15, 2018 | 0.36 |  |
| September 30, 2018 | August 1, 2018 | August 31, 2018 | September 14, 2018 | 0.36 |  |
| December 31, 2018 | October 31, 2018 | November 30, 2018 | December 14, 2018 | 0.36 |  |
| December 31, 2018 | December 6, 2018 | December 20, 2018 | December 28, 2018 | 0.10 | (2) |
| March 31, 2019 | March 1, 2019 | March 20, 2019 | March 29, 2019 | 0.36 |  |
| June 30, 2019 | May 1, 2019 | May 31, 2019 | June 14, 2019 | 0.36 |  |
| September 30, 2019 | July 31, 2019 | August 30, 2019 | September 16, 2019 | 0.36 |  |
| December 31, 2019 | October 30, 2019 | November 29, 2019 | December 16, 2019 | 0.36 |  |
| March 31, 2020 | February 28, 2020 | March 16, 2020 | March 30, 2020 | 0.36 |  |
| June 30, 2020 | April 30, 2020 | June 16, 2020 | June 30, 2020 | 0.36 |  |
| September 30, 2020 | July 30, 2020 | August 31, 2020 | September 15, 2020 | 0.36 |  |
| December 31, 2020 | October 29, 2020 | November 27, 2020 | December 14, 2020 | 0.36 |  |
| December 31, 2020 | December 21, 2020 | December 31, 2020 | January 13, 2021 | 0.10 | (2) |
| March 31, 2021 | February 24, 2021 | March 15, 2021 | March 31, 2021 | 0.36 |  |
|  |  |  | Total cash distributions | $10.42 |  |

(1) The amount of this initial distribution reflected a quarterly distribution rate of $0.30 per share, prorated for the 27 days for the period from the pricing of our initial public offering on March 5, 2014 (commencement of operations), through March 31, 2014.

(2) Represents a special distribution.

For the three months ended March 31, 2021, distributions paid were comprised of interest-sourced distributions (qualified interest income) in an amount equal to 79.1% total distributions paid. As of March 31, 2021, we had estimated undistributed taxable earnings from net investment income of $14.0 million, or $0.45 per share.

### Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to Disclosure Requirements for Fair Value Measurement”, which is intended to improve the effectiveness of fair value measurement disclosures. The amendment, among other things, affects certain disclosure requirements related to transfers between Level 1 and Level 2 of the fair value hierarchy, and Level 3 fair value measurements as they relate to valuation process, unrealized gains and losses, measurement uncertainty, and significant unobservable inputs. The new guidance is effective for interim and annual periods beginning after December 15, 2019. The adoption of these rules did not have a material impact on the consolidated financial statements and disclosures.

In March 2020, the FASB issued ASU 2020-04, “Reference rate reform (Topic 848)—Facilitation of the effects of reference rate reform on financial reporting.” The amendments in this update provide optional expedients and exceptions for applying U.S. GAAP to certain contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform and became effective upon issuance for all entities. The standard is effective as of March 12, 2020 through December 31, 2022. The adoption of these rules did not have a material impact on the consolidated financial statements.

### Recent Developments

#### Redemption of 2022 Notes

On April 5, 2021, the entire $74.75 million aggregate principal amount of 2022 Notes was redeemed in full in accordance with the terms of the indenture governing the 2022 Notes. In connection with the redemption, the 2022 Notes were delisted from the New York Stock Exchange.

#### Distribution

On April 29, 2021, the Board declared a $0.36 per share regular quarterly distribution, payable on June 30, 2021 to stockholders of record on June 16, 2021.

#### Recent Portfolio Activity

From April 1, 2021 through May 4, 2021, we closed $52.0 million of additional debt commitments and funded $23.7 million in new investments. TPC’s direct originations platform entered into $67.0 million of additional non-binding signed term sheets with venture growth stage companies. These investment opportunities for us are subject to due diligence, definitive documentation and investment committee approval, as well as compliance with TPC’s allocation policy. From April 1, 2021 through May 4, 2021, we received $46.0 million of principal prepayments generating more than $2.0 million of accelerated income.

## Market risk

As filed, 6,823 characters.

We are subject to financial market risks, including changes in interest rates. We are also subject to risks relating to the capital markets; conditions affecting the general economy; legislative reform; and local, regional, national or global political, social or economic instability. U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and in values of publicly-traded securities. Any continuation of the stresses on capital markets and credit markets, or a further increase in volatility could result in a contraction of available credit for us and/or an inability by us to access the equity or debt capital markets or could otherwise cause an inability or unwillingness of our lenders to fund their commitments to us, any of which may have a material adverse effect on our results of operations and financial condition.

#### Interest Rate Risk

Interest rate sensitivity refers to the change in our earnings and in the relative values of our portfolio that may result from changes in the level of interest rates. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a change in market interest rates will not have a material adverse effect on our net investment income.

Changes in interest rates may affect both our cost of funding and our interest income from portfolio investments. Our risk management systems and procedures are designed to identify and analyze our risk, to set appropriate policies and limits and to continually monitor these risks. Our investment income will be affected by changes in various interest rates, including LIBOR and the Prime Rate, to the extent that any debt investments include floating interest rates. Debt investments are made with either floating rates that are subject to contractual minimum interest rates for the term of the investment or fixed interest rates.

In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates could reduce our gross investment income and could result in a decrease in our net investment income if such decreases in interest rates are not offset by a corresponding increase in the spread over the Prime Rate that we earn on any portfolio investments, a decrease in our operating expenses or a decrease in the interest rate of our floating interest rate liabilities tied to LIBOR.

As of March 31, 2021, approximately 49.6%, or $292.1 million in principal balance, of the debt investments in our portfolio bore interest at floating rates, which generally are Prime-based, all of which have interest rate floors. Substantially all of our unfunded commitments float with changes in the Prime Rate from the date we enter into the commitment to the date of the actual draw. In addition, our interest expense will be affected by changes in the published LIBOR rate in connection with our Credit Facility to the extent it goes above the floor; however, our 2025 Notes and 2026 Notes bear interest at a fixed rate (subject to a 1.00% increase in the fixed rate in the event that a Below Investment Grade Event (as defined in the Note Purchase Agreement (as modified by the First Supplement with respect to the 2026 Notes) occurs).

As of March 31, 2021, we had no outstanding floating rate borrowings. Due to the fact that our floating rate debt investment portfolio is subject to interest-rate floors set at the current Prime Rate, any increase in interest rates would increase our net investment income as our interest expense would remain constant; however, a decrease in interest rates would not impact our net investment income because all of our floating rate debt investment portfolio has interest rate floors above the current Prime Rate. This is illustrated in the following table which shows the annual impact on net investment income of base rate changes in interest rates (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure from the March 31, 2021 consolidated statement of assets and liabilities:

| Change in Interest Rates (in thousands) | Increase (decrease) in interest income | (Increase) decrease in interest expense | Net increase (decrease) in net investment income |
| --- | ---: | ---: | ---: |
| Up 300 basis points | $4,360 | $— | $4,360 |
| Up 200 basis points | $1,674 | $— | $1,674 |
| Up 100 basis points | $744 | $— | $744 |
| Up 50 basis points | $372 | $— | $372 |
| Down 50 basis points | $— | $— | $— |
| Down 100 basis points | $— | $— | $— |
| Down 200 basis points | $— | $— | $— |
| Down 300 basis points | $— | $— | $— |

This analysis is indicative of the potential impact on our investment income as of March 31, 2021, assuming an immediate and sustained change in interest rates as noted. It should be noted that we anticipate growth in our portfolio funded in part with additional borrowings and such additional borrowings, all else being equal, will increase our investment income sensitivity to interest rates, and such changes could be material. In addition, this analysis does not adjust for potential changes in our portfolio or our borrowing facilities nor does it take into account any changes in the credit performance of our loans that might occur should interest rates change.

Because it is our intention to hold loans to maturity, the fluctuating relative value of these loans that may occur due to changes in interest rate may have an impact on unrealized gains and losses during quarterly reporting periods. Based on our assessment of the interest rate risk, as of March 31, 2021, we had no hedging transactions in place as we deemed the risk acceptable, and we did not believe it was necessary to mitigate this risk at that time.

While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of lower interest rates with respect to our portfolio investments. In addition, there can be no assurance that we will be able to effectively hedge our interest rate risk.

Substantially all of our assets and liabilities are financial in nature. As a result, changes in interest rates and other factors drive our performance more directly than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates.

## Controls and procedures

As filed, 1,718 characters.

### Evaluation of Disclosure Controls and Procedures

As of March 31, 2021 (the end of the period covered by this report), we, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended). Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

### Changes in Internal Controls Over Financial Reporting

Management has not identified any change in the Company’s internal control over financial reporting that occurred during the quarter ended March 31, 2021 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 897 characters.

You should carefully consider the risks referenced below and all other information contained in this Quarterly Report on Form 10-Q, including our interim financial statements and the related notes thereto, before making a decision to purchase our securities. Any such risks and uncertainties are not the only ones facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may have a material adverse effect on our business, financial condition and/or operating results, as well as the market price of our securities.

There have been no material changes during the three months ended March 31, 2021 to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020 (filed with the SEC on March 3, 2021), which could materially affect our business, financial condition or operating results.

Filed May 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001580345-21-000020. Last ingested by Listed: Nov 4, 2026, 18:08 ET. No prices; not investment advice.
